Koyfin Home > Directory > Communication Services > Central EUR Med A > EBITDA

Central EUR Med A EBITDA Chart (CETV)

Central EUR Med A annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Central EUR Med A EBITDA for the quarter ending June 06, 2020 was $52m a 25.16% increase of 13m year over year
  • Central EUR Med A EBITDA for the last 12 months ending June 06, 2020 was $230m a -6.32% decrease of -15m year over year
  • Central EUR Med A Annual EBITDA for 2019 was $248m a 10.18% increase of 25m from 2018
  • Central EUR Med A Annual EBITDA for 2018 was $223m a 19.27% increase of 43m from 2017
  • Central EUR Med A Annual EBITDA for 2017 was $180m a 21.26% increase of 38m from 2016
Other Income Statement Metrics:
  • Central EUR Med A Net Income for the quarter ending December 12, 2018 was $56m a 87.01% increase of 49m year over year
  • Central EUR Med A Total Revenue for the quarter ending December 12, 2018 was $228m a 39.02% increase of 89m year over year
View Chart On Koyfin

Quarterly CETV EBITDA Data

06/2020$52m
03/2020$34m
12/2019$104m
09/2019$39m
06/2019$69m
03/2019$36m
12/2018$101m
09/2018$30m
06/2018$59m
03/2018$33m

Annual CETV EBITDA Data

2019$248m
2018$223m
2017$180m
2016$142m
2015$123m
2014$93m
2013$23m
2012$139m
2011$167m
2010$112m